Interview

Gilead's Rashad Burgess is Advancing Health and Equity in LGBTQ Communities of Color

Before Rashad Burgess held the professional title of Vice President of Advancing Health and Equity at Gilead Sciences or the personal identification of husband and father, he witnessed the devastating effects of HIV in the early nineties as a gay teenager growing up on the south side of Chicago. As it did then, today, the disproportionate impact of HIV in the Black community experienced by Black gay men continues to fuel Burgess' work.

"I got to see what happens when you have inequity and communities being disproportionately impacted by HIV," Burgess tells The Reckoning. "I've always felt a call to make a difference in communities that felt like they were on the margins or felt vulnerable. No matter what role I've had in my career, that has driven me."

Formerly the Branch Chief of Capacity Building in the HIV/AIDS Prevention division at the Centers for Disease Control and Prevention (CDC), Burgess has dedicated most of his adult life and the last nine years with Gilead Sciences toward decreasing the impact of HIV in Black communities. In July, he stepped into his new role at Gilead Sciences as Vice President of Advancing Health and Equity.

The Reckoning spoke with Burgess about Gilead's efforts to tackle the HIV epidemic in the South. In a wide-ranging conversation, Burgess talks about Gilead's $100 million COMPASS Initiative, the impact of COVID-19 on testing and care, the importance of education and access to PrEP to curb new acquisitions, and why he believes the epidemic will end in his lifetime.

Gilead's Rashad Burgess is Advancing Health and Equity in LGBTQ Communities of Color